Chimeric virus-like particles and capsomeres induce similar CD8(+)T cell responses but differ in capacity to induce CD4(+)T cell responses and antibody responses
Journal Publication ResearchOnline@JCUAbstract
Despite extensive research, the development of an effective malaria vaccine remains elusive. The induction of robust and sustained T cell and antibody response by vaccination is an urgent unmet need. Chimeric virus-like particles (VLPs) are a promising vaccine platform. VLPs are composed of multiple subunit capsomeres which can be rapidly produced in a cost-effective manner, but the ability of capsomeres to induce antigen-specific cellular immune responses has not been thoroughly investigated. Accordingly, we have compared chimeric VLPs and their sub-unit capsomeres for capacity to induce CD8(+)and CD4(+)T cell and antibody responses. We produced chimeric murine polyomavirus VLPs and capsomeres each incorporating defined CD8(+)T cell, CD4(+)T cell or B cell repeat epitopes derived fromPlasmodium yoeliiCSP. VLPs and capsomeres were evaluated using both homologous or heterologous DNA prime/boost immunization regimens for T cell and antibody immunogenicity. Chimeric VLP and capsomere vaccine platforms induced robust CD8(+)T cell responses at similar levels which was enhanced by a heterologous DNA prime. The capsomere platform was, however, more efficient at inducing CD4(+)T cell responses and less efficient at inducing antigen-specific antibody responses. Our data suggest that capsomeres, which have significant manufacturing advantages over VLPs, should be considered for diseases where a T cell response is the desired outcome.
Journal
Frontiers in Immunology
Publication Name
N/A
Volume
11
ISBN/ISSN
1664-3224
Edition
N/A
Issue
N/A
Pages Count
13
Location
N/A
Publisher
Frontiers Research
Publisher Url
N/A
Publisher Location
N/A
Publish Date
N/A
Url
N/A
Date
N/A
EISSN
N/A
DOI
10.3389/fimmu.2020.564627